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Fast-Response Calmodulin-Based 
Fluorescent Indicators Reveal 
Rapid Intracellular Calcium 
Dynamics
Nordine Helassa1, Xiao-hua Zhang2, Ianina Conte1,3, John Scaringi2, Elric Esposito4, 
Jonathan Bradley4, Thomas Carter1,3, David Ogden4, Martin Morad2 & Katalin Török1
Faithful reporting of temporal patterns of intracellular Ca2+ dynamics requires the working range 
of indicators to match the signals. Current genetically encoded calmodulin-based fluorescent 
indicators are likely to distort fast Ca2+ signals by apparent saturation and integration due to their 
limiting fluorescence rise and decay kinetics. A series of probes was engineered with a range of 
Ca2+ affinities and accelerated kinetics by weakening the Ca2+-calmodulin-peptide interactions. At 
37 °C, the GCaMP3-derived probe termed GCaMP3fast is 40-fold faster than GCaMP3 with Ca2+ decay 
and rise times, t1/2, of 3.3 ms and 0.9 ms, respectively, making it the fastest to-date. GCaMP3fast 
revealed discreet transients with significantly faster Ca2+ dynamics in neonatal cardiac myocytes 
than GCaMP6f. With 5-fold increased two-photon fluorescence cross-section for Ca2+ at 940 nm, 
GCaMP3fast is suitable for deep tissue studies. The green fluorescent protein serves as a reporter 
providing important novel insights into the kinetic mechanism of target recognition by calmodulin. 
Our strategy to match the probe to the signal by tuning the affinity and hence the Ca2+ kinetics of 
the indicator is applicable to the emerging new generations of calmodulin-based probes.
Visualising Ca2+ fluxes in cells, tissues or free-moving animals offers an important way of gaining under-
standing of a wide range of physiological mechanisms including cardiac function, cell signalling and neu-
ronal network activity. Monitoring fast or high frequency Ca2+ transients, characteristic of excitable cells, 
requires rapid kinetics with millisecond time resolution. Genetically encoded fluorescent Ca2+ indicators 
(GECI) are being developed to fulfil these roles and have become important tools for activity studies 
using targeted expression in cultured cells and tissues and in live transgenic animals1.
Green fluorescent protein - calmodulin protein - (GCaMP)-type GECI are based on a circularly per-
mutated EGFP molecule (cpEGFP)2 flanked at the N and C termini by the smooth muscle myosin light 
chain kinase derived calmodulin binding peptide (RS20) and calmodulin (CaM), respectively3. The pre-
ferred protonated state of cpEGFP has low brightness. Its intrinsic fluorescence is enhanced by Ca2+ 
binding, which causes the Ca2+.CaM.RS20 complex to form, stabilizing the highly fluorescent, deproto-
nated form of GCaMP by blocking solvent access to the chromophore4,5.
Several generations of GCaMP-type GECI obtained by mutagenesis have presented improvements 
in brightness, signal-to-noise ratio and photostability6–16. Mutations to the linker regions and to the 
cpEGFP domain itself resulted in greater fluorescence enhancements on Ca2+ binding by shifting the 
equilibrium towards the deprotonated state and/or increasing the brightness of the deprotonated form. 
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These mutations, however, left unchanged the high affinity (equilibrium dissociation constant Kd in the 
range of hundreds of nM) and concomitant slow response kinetics of the probes to Ca2+. There has 
been a lack of insight into the onset kinetics and slow fluorescence decay rates of 1–5 s−1 have con-
strained tracking rapid processes. In excitable cells monitoring fast Ca2+ fluxes requires millisecond time 
resolution and thus fluorescence decay and rise rates of up to 1000 s−1. These issues have begun to be 
addressed17,18, however, to-date there are no GECI probes sufficiently rapid for accurate tracking of fast 
or high-frequency Ca2+ transients associated with synaptic transmission and activation of skeletal and 
cardiac muscle.
Our aim was to generate fast derivatives of GCaMP3 by rational design with Ca2+ response kinetics 
on the millisecond time scale and to understand the kinetic mechanisms by which GCaMPs respond to 
Ca2+ concentration changes. Using both excitable and non-excitable cellular model systems we compared 
the response kinetics of the newly developed probes with those of the chemical dye Fura-2, GCaMP3 
and GCaMP6f. Imaging with the newly developed probe GCaMP3fast revealed significantly faster Ca2+ 
response kinetics than previously seen with GECI.
Results
Design of fast-response GCaMPs. The high affinity of GCaMPs for Ca2+ (Kd of 100 - 300 nM8,11,15) 
is determined by the equilibrium of the Ca2+.CaM.RS20 peptide complex. We have previously shown 
that the mutation of the Trp residue to Tyr in a RS20-related peptide increases the Kd of the com-
plex for Ca2+.CaM19,20. Moreover, disabling individual EF-hand Ca2+ binding sites of CaM by single 
point mutations (Asp → Ala) in the first loop residue of each EF-hand increased the Kd of CaM for Ca2+ 21,22. 
As a consequence, Ca2+ dissociation from complexes of Ca2+-bound EF-hand mutated CaM with a peptide 
derived from α CaMKII (CaMKIIP) was significantly accelerated. Based on these observations our hypothesis 
was that fast Ca2+ response rates can be achieved for GCaMPs by weakening the Ca2+.CaM.RS20 interaction 
by the peptide and EF-hand mutations described above.
Our strategy therefore was to disable from one to three of the four EF-hand Ca2+ binding sites in the 
CaM sequence in GCaMP3-derived proteins, and to investigate the effect of Trp → Tyr mutation in the 
RS20 target peptide sequence, alone, and in combination with the EF-hand mutations (Fig. 1a,b).
Triple EF-hand mutations in all cases resulted in a loss of fluorescence response to Ca2+ binding, 
and were not studied further. The following single and double EF-hand mutants were generated and 
characterised – the numbers identify the mutated EF-hand(s): EF-1, EF-2, EF-3, EF-4, EF-1:2, EF-1:3, 
EF-1:4, EF-2:3, EF-2:4, EF-3:4. The Trp → Tyr peptide mutant was termed RS-1 and the peptide muta-
tion combined with mutation of the first EF-hand gave RS-1 EF-1 and so on, resulting all together in 21 
GCaMP3 mutants (mGCaMP3). The same EF-hand mutagenesis strategy that was applied to GCaMP3 
was also tested on two of its derivatives developed by Zhao et al.11, giving 20 additional mutants. The 
properties of 41 mutants are presented in Supplementary Materials, Supplementary Fig. S3, S5–S8, S11 
and Supplementary Tables S1–S4).
Detailed characterisation is presented below of two mGCaMP3 probes: GCaMP3fast (mGCaMP3 RS-1 
EF-3) with the fastest Ca2+ response times is promising for monitoring high-frequency Ca2+ transients 
and GCaMP3bright (mGCaMP3 EF-4) with the highest fluorescence dynamic range. Other mutants pre-
sented in Supplementary Table S2 show features such as high Kd (mM range) that are potentially useful 
for monitoring Ca2+ in organelles. Indicator responses occurred on the millisecond time scale and thus 
Ca2+ response kinetics were assessed by stopped-flow. A kinetic model proposed to explain the Ca2+ 
response mechanism of GCaMP3 and mGCaMP3 is illustrated on GCaMP3fast and GCaMP3bright (with-
out the red star at P2 that signifies the RS-1 mutation) (Fig.  1c and Supplementary Fig. S13). Fitted 
parameters for GCaMP3fast and GCaMP3bright and further five mGCaMP3 probes of potential interest in 
physiological studies are presented (Supplementary Table S3).
Biophysical characterisation of mutant GCaMP3 probes. Mutations in the peptide and CaM 
EF-hands did not affect the stability of the proteins. Fluorescence emission of GCaMP3fast was stable at 
37 °C for four hours, in the absence and presence of Ca2+ (Supplementary Fig. S1). Relative fluorescence 
of GCaMP3 in the presence of Ca2+ ( )(+ )+F r Ca2  was 6.3 compared to Ca2+-free GCaMP3, the fluorescence 
intensity of which was defined to have relative fluorescence ( )(− )+F r Ca2  of 1. The GCaMP3fast and 
GCaMP3bright probes had somewhat lower ( )(+ )+F r Ca2  and ( )(− )+F r Ca2  values than GCaMP3 but their Ca2+ 
binding-induced fluorescence enhancement was greater: 9-fold for GCaMP3fast and 14-fold for 
GCaMP3bright (Table  1). Quantum yield (Φ ) measurements revealed that the mutations did not cause 
large changes compared to GCaMP3. Using the value Φ +Ca2+ of 0.44 as a reference we obtained Φ −Ca2+ 
of 0.21, essentially the same as previously described11. GCaMP3fast had Φ +Ca2+ of 0.42 and Φ −Ca2+ of 0.14, 
while Φ +Ca2+ was 0.35 and Φ −Ca2+ 0.09 for GCaMP3bright. pKa values were 7.5–8 in the presence and ~8.2 
in the absence of Ca2+ for all three probes (Supplementary Fig. S2).
Simultaneous mutation of both C-lobe Ca2+ binding sites (mGCaMP3 EF-3:4) moderately reduced 
the fluorescence dynamic range (Supplementary Table S1). However, mutation of either of the N-terminal 
Ca2+ binding sites EF-1 or EF-2 was severely detrimental to the Ca2+ response and double mutant EF-1:2 
was essentially non-responsive to Ca2+ (Supplementary Table S2). The N-lobe Ca2+ binding sites are thus 
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critical for functional probes, whereas mutation of C-lobe sites can improve the fluorescence dynamic 
range of GCaMPs.
Most of the mGECI generated had higher Kd values and faster fluorescence decay rates than the 
equivalent wild type protein (Fig.  2a–c, Supplementary Fig. S3–S5 and Supplementary Tables S1, S2). 
Figure 1. Design of mGCaMPs and kinetic mechanism of Ca2+-induced fluorescence changes. (a) Crystal 
structure of monomeric GCaMP2 in a Ca2+-bound form with the RS20 peptide (purple), cpEGFP (green) 
and CaM (blue) (adapted from Akerboom et al.4). The approximate position of the mutations in the CaM 
EF-hand Ca2+-binding sites is shown by arrows and in the RS20 peptide by a red star. (b) Domain structure 
of GCaMP3. The mutated residues and their positions in the primary structure are highlighted in red. (c) 
Schematic model of the kinetic mechanism of Ca2+-induced fluorescence of GCaMP3fast. For the GCaMP3fast 
mutant the disabled CaM C-lobe EF-hand is painted red and the RS-1 mutation is indicated by a red star. 
For fitting the model to the data, Ca2+ binding to EF-3, corresponding to equation (5) of Supplementary Fig. 
S14, was omitted. Ca2+ binding to the CaM N-lobe is followed by the development of the first fluorescent 
state (F1) by peptide binding at the P1 site and a structural change. N-lobe Ca2+-bound CaM proceeds to 
full Ca2+ binding and complete peptide binding at the P2 site, which, following a structural rearrangement, 
presents the second fluorescent state (F2). Ca2+ dissociation occurs directly from the two fluorescent states. 
Fitted parameters are shown in Supplementary Table S3. For GCaMP3bright, the diagram without the red star 
applies and equation (6) was absent for the data fitting.
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Equilibrium dissociation constants (Kd) obtained by Ca2+ titration were increased from 330 nM for 
GCaMP3 to 1–3 μ M for GCaMP3fast and GCaMP3bright. Cooperativity of Ca2+ binding, characterised 
by a Hill coefficient (n) of 3.2 for GCaMP3 was higher, 4.3 and 4.7, for GCaMP3fast and GCaMP3bright, 
making their switch-like Ca2+ response steeper than that of GCaMP3 (Fig. 2a and Table 1).
The kinetics of Ca2+ response of GCaMP3 and mGCaMP3 were measurable by stopped-flow kinetics 
with the limitation of a ~1.5 ms response time allowing the measurement of rates up to ~500 s−1. The 
most significant improvements in the Ca2+ dissociation kinetics of GCaMP3 were achieved by the com-
bination of the RS-1 and EF-3 mutations. At 20 °C, the t1/2 of 461 ms for Ca2+ dissociation of GCaMP3 
was reduced to 11 ms (3.3 ms at 37 °C) with the GCaMP3fast probe (t1/2 values were calculated from the 
dissociation rates measured at the indicated temperatures, Fig. 2b,d, Table 1 and Supplementary Fig. S4).
Investigation of the kinetics of fluorescence changes upon Ca2+ association revealed novel fea-
tures. First, a limiting rate (kon(lim)) was observed for all GECI and mGECI generated in this study. For 
GCaMP3 at physiological ionic strength and 20 °C the rate saturated at 20 s−1 (Supplementary Fig. S4 
and Table 1), corresponding to a rise time (t1/2) of 35 ms. The GCaMP3fast and GCaMP3bright mutations 
increased the limiting rate to ~140 s−1 (20 °C). Second, the observed rates showed a steep dependence 
on [Ca2+]. Consistent with their increased cooperativity for Ca2+ compared to GCaMP3, the observed 
rates of the two mutants switched to a limiting maximum over a narrow range of [Ca2+] around their 
dissociation constants (Fig. 2e,g and Table 1). A number of other mGECI also showed high cooperativity 
(Supplementary Fig. S6–S8 and Supplementary Tables S1, S2). Third, biphasic fluorescence rise kinetics 
were found in GCaMP3bright with saturating rates at 135 s−1 and 19 s−1. Each phase represented 50% of 
the total amplitude, revealing the existence of two distinct fluorescent conformers (Figs 1c and 2g and 
Table 1). Fourth, strikingly, the limiting fluorescence rise rates of GCaMP3 and GCaMP3bright were essen-
tially independent of temperature in the temperature range of 20 °C to 37 °C. The faster and slower phases 
of GCaMP3bright saturating at 135 s−1 and 19 s−1 at 20 °C increased only to 139 s−1 and 26 s−1 at 37 °C. In 
contrast, GCaMP3fast showed marked temperature dependences with rates increased to 411 s−1 at 30 °C. 
The time resolution did not permit direct measurement at 37 °C. The limiting rate was extrapolated from 
Arrhenius plots giving a fluorescence rise rate of 743 s−1 for GCaMP3fast at 37 °C (Fig. 2i and Table 1). 
GCaMP3fast and GCaMP3bright presenting the fastest responses to Ca2+ in combination with the highest 
dynamic ranges were selected for further physiological characterization.
Monitoring fast Ca2+ transients in neonatal cardiac myocytes with GCaMP3fast. Neonatal car-
diac myocytes were chosen for the fast kinetics and physiological relevance of their Ca2+ transients. 
In spontaneously beating neonatal cardiac myocytes, where spontaneous pacing is seen as rhythmic 
Ca2+ releases, comparison of the fluorescence rise times of GCaMP3 (60 ms), GCaMP6f (68 ms) and 
GCaMP3fast (39 ms) showed that GCaMP3fast was ~1.5-fold faster than either of the other two probes 
(Fig. 3a,b,d). The fluorescence decay times for GCaMP3 (222 ms), GCaMP6f (135 ms) and GCaMP3fast 
(71 ms) were even more markedly improved, GCaMP3fast was 3-fold faster than GCaMP3 and twice as 
fast as GCaMP6f (Fig.  3a,b,e). Response kinetics were similarly strikingly improved to caffeine stimu-
lation with fluorescence decay times 4-fold reduced for GCaMP3fast compared to GCaMP3 and 2-fold 
reduced compared to GCaMP6f (Fig.  3c,f). Remarkably, significantly faster kinetics of intracellular 
Ca2+ rise and fall were recorded in patch-clamped myocytes on activation of ICa-gated Ca2+ release 
(CICR) with GCaMP3fast compared to the other two probes (rise-times 44 ms for GCaMP3 and 43 ms 
for GCaMP6f compared to 33 ms for GCaMP3fast and decay-times of 245 ms for GCaMP3 and 168 ms for 
Protein
Fr
/+ + − +( ) ( )F Fr Ca r Ca2 2 Kd (μM) n
kon(lim) (s−1) koff (s−1) σ2 (10−50 cm4.s.photon−1)
−Ca2+ +Ca2+ 20 °C 37 °C 20 °C 37 °C −Ca2+ +Ca2+
GCaMP3 1.0 6.3 6.3 0.33 ± 0.01 3.2 ± 0.1 20 ± 1 19 ± 1 1.5 ± 0.1 5.3 ± 1 0.06a 0.76a
mGCaMP3 RS-1 EF-3 
(GCaMP3fast)
0.6 5.1 8.8 2.8 ± 0.3 4.3 ± 0.2 145 ± 2 743b 62 ± 2 210 ± 6 0.1 0.47
mGCaMP3 EF-4  
(GCaMP3bright)
0.3 4.2 14 0.93 ± 0.01 4.7 ± 0.1 135 ± 8 (0.5)
c 
19 ± 1 (0.5)c
139 ± 41 (0.5)c 
26 ± 2 (0.5)c 2.8 ± 0.1 15 ± 0.2 0.22 2.00
Table 1.  Summary of the biophysical characteristics of GCaMP3fast and GCaMP3bright probes. Relative 
fluorescence increase ( / )(+ ) (− )+ +F Fr Ca r Ca2 2 , Kd and Hill coefficient (n) values were obtained from the 
equilibrium Ca2+ binding titrations at 20 °C. Fluorescence rise (limiting rate, kon(lim)) and decay (koff) rates 
were measured by Ca2+ association and dissociation stopped-flow kinetic experiments both at 20 °C and 
37 °C. Two-photon cross-section (σ 2) values were determined from two-photon excitation spectra at 940 nm, 
unless otherwise specified, using fluorescein as a reference. aRecorded at 930 nm. bMeasurements were made 
at 20, 25 and 30 °C. Rates were too fast to measure at 37 °C, thus value was extrapolated from Arrhenius plot 
(Fig. 2i). cBiphasic association kinetic records were fitted with two exponentials. The rate of each phase is 
given with the relative amplitudes in parentheses. Error represents the standard error of the estimate for the 
average of three records.
www.nature.com/scientificreports/
5Scientific RepoRts | 5:15978 | DOi: 10.1038/srep15978
Figure 2. Biophysical characterisation of GCaMP3fast and GCaMP3bright. (a) Equilibrium Ca2+ titrations 
for: GCaMP3 (● ), GCaMP3fast ( ) and GCaMP3bright ( ). Fluorescence changes are normalised to F0 of 0 
and Fmax of 1 and fitted to the Hill equation. Fitted curves are represented by solid lines overlaying the data; 
(b,c) Dissociation kinetics of GCaMP3fast ( ) and GCaMP3bright ( ) fitted to single exponentials. Intensities 
are relative to Ca2+-bound GCaMP3. Experimental data (dotted lines) are overlaid with fitted curves (solid 
lines) generated using the parameters shown in Supplementary Table S3 fitted to the model in Supplementary 
Fig. S13; (d) Arrhenius plots of the observed dissociation rates of GCaMP3 (● ), GCaMP3fast ( ) and 
GCaMP3bright ( ) recorded at 20, 25, 30, 37 °C; (e–h) Association kinetics. (e) Plot of the [Ca2+] dependence 
of the observed rate(s) (kobs) for GCaMP3fast; (f) stopped-flow records for GCaMP3fast at 2 μ M ( ), 5 μ M 
( ), 10 μ M ( ) and 20 μ M ( ) [Ca2+]. Fluorescence changes are normalised to F0 of 0 and Fmax of 1. 
Experimental data (dotted lines) are overlaid with fitted curves (solid lines) generated using the parameters 
shown in Supplementary Table S3 fitted to the model in Supplementary Fig. S13; (g) Plot of the [Ca2+] 
dependence of the observed rate(s) (kobs) for GCaMP3bright; (h) stopped-flow records for GCaMP3bright at 
0.24 μ M ( ), 0.45 μ M ( ), 1 μ M ( ) and 5 μ M ( ) [Ca2+]. Experimental data (dotted lines) are 
overlaid with fitted curves (solid lines) generated using the parameters shown in Supplementary Table S3 
fitted to the model in Supplementary Fig. S13. As GCaMP3bright has biphasic kinetics, the slower rate is 
shown in red and the faster rate in black; (i) Arrhenius plots of the observed association rates of GCaMP3 
(● ), GCaMP3fast ( ) and GCaMP3bright ( ) recorded at 20, 25, 30, 37 °C. For mGCaMP3 with biphasic 
kinetics, the slower process is shown in dotted line and the faster process is in solid line.
GCaMP6f compared to 95 ms for GCaMP3fast) (Fig. 3g–i). While Δ F/F0 is a modest 0.2 when measured 
throughout an entire beating cell (Fig. 3g), the fluorescence dynamic range of localized perinuclear Ca2+ 
signals recorded at 120 Hz, at the hotspots reaches ~1 (Supplementary Fig. S9).
Live cell imaging of GCaMP3fast and GCaMP3bright in human endothelial cells and embryonic 
kidney cells. Imaging the fluorescence of GCaMP3fast and GCaMP3bright in the cellular environment 
of human umbilical vein endothelial cells (HUVEC) and HEK293T cells revealed no detectable dam-
age to cell viability. Fluorescence dynamic ranges (Δ F/F0) of mGCaMP3 expressed in the cytosol of 
HUVEC during acute exposure to ionomycin remained high with values of 3.4 and 5.6 for GCaMP3fast 
and GCaMP3bright respectively, comparable to GCaMP3 (Fig. 4a,b and Supplementary Tables S1, S2).
The kinetics of GCaMP3 and mGCaMP3 fluorescence changes were compared with those of the Ca2+ 
dye Fura-2 by simultaneous imaging. Extracellular ATP-induced Ca2+ transients were reported with simi-
lar kinetics by both Fura-2 and GCaMP3 in HUVEC and HEK293T cells (Fig. 4c and Supplementary Fig. 
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Figure 3. Comparison of the kinetics of GCaMP3, GCaMP6f and GCaMP3fast in neonatal 
cardiomyocytes. Recorded by GCaMP3 (─    ), GCaMP6f ( ) and GCaMP3fast ( ) are: (a) spontaneous 
whole-cell cytosolic Ca2+ signals in Ad-CMV-virus infected cells imaged confocally at 120 Hz (n ≥ 10); (b) 
expanded beats, marked by stars; (c) representative traces of Ca2+ release after application of 3 mM caffeine 
(n ≥ 9), imaged confocally at 30 Hz; (d) average values of 70% Ca2+ rise time in spontaneously beating 
cardiac myocytes; (e) average values of 70% Ca2+ decay time in spontaneously beating cardiac myocytes; (f) 
average values of 70% relaxation time after caffeine application; (g) Ca2+ current activated Ca2+ release 
(CICR) in voltage clamped neonatal cardiomyocytes (n ≥ 7), imaged confocally at 120 Hz. Cells are voltage 
clamped at − 50 mV and depolarized to 0 mV; (h) average values of depolarization-activated 70% Ca2+ rise 
time; (i) average values of depolarization-activated 70% relaxation time.
www.nature.com/scientificreports/
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S10). The fluorescence of both Fura-2 and GCaMP3 reached a plateau before slowly declining with com-
plex kinetics (Fig.  4c–e and Supplementary Fig. S10). In contrast, GCaMP3fast and GCaMP3bright fluores-
cence response to hormone stimulation was characterised by rise to a sharp peak followed by exponential 
decline to baseline (Fig. 4d,e and Supplementary Fig. S10). The fluorescence rise times for GCaMP3fast and 
GCaMP3bright and the decay time for GCaMP3fast were significantly faster than either Fura-2 or GCaMP3 
(Fig.  4f,g and Supplementary Fig. S10). GCaMP3fast responded with a 0.22 ± 0.08 s rise and a 3.2 ± 0.4 s 
decay time in ATP stimulated HUVEC (Fig.  4f,g). Δ F/F0 values are reciprocal to Kd-s indicating Fura-2 
and GCaMP3 to be saturated. In contrast, the lower affinity GCaMP3fast and GCaMP3bright probes with less 
than maximum fluorescence enhancement show partial binding. These data altogether suggest comparable 
peak values for [Ca2+] in the range 0.5–1 μ M (Supplementary Fig. S10).
Two-photon cross-sections of mGCaMPs of mGECI. Because animal tissue is transparent to infra-
red light, two-photon excitation microscopy has become a crucial tool for tissue and in vivo fluorescence 
imaging. Two-photon excitation fluorescence cross-section (σ 2) or two-photon absorption represents the 
absorption coefficient for the simultaneous absorption of two photons for the excitation of a fluorophore. 
Although the depth of penetration is limited by the wavelength, the signal strength and signal-to-noise 
ratio will depend on the absolute value of σ 2. Hence we determined the σ 2 values the novel mGECI in the 
presence and absence of Ca2+ relative to fluorescein23 (Fig. 4h,i and Supplementary Fig. S11). Compared 
to the 21 × 10−50 cm4.s.photon−1 value for fluorescein, GCaMP3 had the lowest σ 2 value in the absence of 
Ca2+ (0.06 × 10−50 cm4.s.photon−1). In the presence of Ca2+ the σ 2 value increased to 0.76 × 10−50 cm4.s.
photon−1. The GCaMP3fast probe had a ~5-fold increase upon Ca2+ binding. The brightest probe with 
the greatest fluorescence dynamic range under two-photon excitation was GCaMP3bright with a ~10-fold 
increase and higher σ 2 values, 0.22 × 10−50 cm4.s.photon−1 and 2.0 × 10−50 cm4.s.photon−1, in the pres-
ence and absence of Ca2+, respectively. It is envisaged that the probes developed here will be useful to 
study fast signalling processes, such as the Ca2+ changes associated with neuronal activity in tissues and 
in vivo.
Discussion
Based on previous studies19,21 we devised a rational approach to alter the kinetic properties of GCaMPs 
for better detection of fast Ca2+ signalling events. Disabling the function of individual Ca2+ binding sites 
by single point mutations in the CaM portion of GCaMPs was expected to lower the Ca2+ affinity and 
accelerate Ca2+ kinetics21. Weakening the Ca2+.CaM - peptide interaction by mutation of the RS20 pep-
tide was expected to further lower Ca2+ affinity as substitution of the Trp residue with Tyr was known 
to increase the Kd for peptide binding to Ca2+.CaM19,20. Consistent with our predictions, CaM EF-hand 
and peptide RS-1 mutations of GCaMP3 resulted in increasing the Kd for Ca2+ binding from 330 nM 
to 1–3 μ M. Fura-2 and GCaMP3 with sub-μ M Kd for Ca2+ showed slow and complex Ca2+ response 
kinetics in ATP-stimulated in HUVEC and HEK293T cells, indicating probe saturation. GCaMP3fast and 
GCaMP3bright revealed that the hormone-induced Ca2+ transients were faster than when reported either 
by Fura-2 or GCaMP3. Our data thus show that the amplitude and kinetics of hormone-evoked intra-
cellular Ca2+ transients are better matched by Ca2+ probes with a μ M working range, like GCaMP3fast 
and GCaMP3bright, than by those with Kd values for Ca2+ of 200–300 nM.
A major limitation of GCaMP3 in faithfully tracking Ca2+dynamics has been its slow Ca2+ dissocia-
tion (t1/2 of 131 ms) at 37 °C. Recently reported probes GCaMP6 ‘fast’ (GCaMP6f)15 (t1/2 of 66 ms (37 °C) 
(N. Helassa and K. Török, unpublished data)), the RS09 GCaMP3 mutant18 (t1/2 of 25 ms, (37 °C)) and 
fast-GCaMP6f-RS09 (t1/2 of 20 ms (37 °C))24 have faster dissociation kinetics. Our GCaMP3fast probe with 
a t1/2 of 3.3 ms for fluorescence decay at 37 °C is the fastest currently available GECI.
The maximal fluorescence onset rates determine the time resolution at which fluorescence changes 
are detected by the probes. Response times of > 50 ms for GCaMP6f, fast-GCaMP6f-RS06 and 
fast-GCaMP6f-RS09 were measured in mammalian brain slices. When compared to times to peak of Ca2+ 
transient measurements with the fast linear-response fluorescent dye Furaptra of 36 ms in patch-clamped 
cardiac myocytes25, 6.3 ms in electrically stimulated frog skeletal muscle26, 13 ms in endothelial cells for 
IP3-evoked Ca2+ release27 and 35 ms in Purkinje neurons for IP3-evoked Ca2+ release28, it is evident that 
the kinetics of GCaMP3fast are not limiting the detection of fast Ca2+ transients in cells. The RS-1 and 
EF-hand mutations resulted in up to 40-fold higher rates compared to GCaMP3, taking the response 
times of GCaMP3fast down to just under 1 ms at 37 °C.
We compared the response kinetics of GCaMP3fast to GCaMP3 and GCaMP6f in a fast response 
physiological system. In neonatal cardiac myocytes Ca2+ rise and decays times were significantly faster 
during spontaneous beating, after caffeine stimulation and in ICa-gated Ca2+ release when recorded using 
GCaMP3fast. In contrast to GCaMP3 and GCaMP6f, GCaMP3fast revealed entirely discrete Ca2+ oscilla-
tions in spontaneously beating cardiac myocytes with a 2.5-fold shorter duration (~210 ms) compared to 
GCaMP6f (~535 ms) for each oscillatory calcium spike. GCaMP3fast thus shows greater time resolution 
and is more suitable for tracking fast Ca2+ transients than GCaMP6f. In cardiac myocytes following 
50 ms depolarisation, Furaptra had 29 ms time to peak rise and 66 ms decay times25. Our measured rise 
and decay times of GCaMP3fast in cardiac myocytes following 100 ms depolarisation were a comparable 
33 ms and 96 ms, respectively (Fig. 3h,i), suggesting that the Ca2+ rise and fall times measured in cardiac 
myocytes were not limited by the Ca2+ response kinetics of GCaMP3fast.
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Figure 4. Characterisation and application of selected mGCaMP3 in HUVEC. Fura-2 ( ), GCaMP3 ( ), 
GCaMP3fast ( ) and GCaMP3bright ( ): (a) signals are recorded by live cell imaging. Ca2+ influx is evoked 
by ionomycin. Image frames taken at times 0.4 s, 0.8 s, 2.67 s and 4.40 s are shown. (b) fluorescence dynamic 
ranges following ionomycin treatment (n ≥ 12); (c–e) representative records following exposure to 2 μ M ATP. 
Comparison of: (c) GCaMP3 with Fura-2; (d) GCaMP3 with GCaMP3fast and GCaMP3bright; (e) GCaMP3fast 
with Fura-2. Fluorescence rise times (f) and decay times (g) for Fura-2, GCaMP3, GCaMP3fast and 
GCaMP3bright (n ≥ 5) following ATP stimulation. Two-photon excitation spectra of (h) GCaMP3fast ( ); (i) 
GCaMP3 (● ) and GCaMP3bright ( ). Spectra are taken in the presence (solid lines) and in the absence (dotted 
lines) of Ca2+.
Extensive quantitative studies on [Ca2+] in cultured endothelial cells have been previously made 
with the low affinity indicator Furaptra27,29. The rising phase of Ca2+ transients in endothelial cells is 
fast and the peak [Ca2+] high, reaching 20 μ M, as shown in experiments either with ATP stimula-
tion or intracellular store release by photo-released InsP327 or for acetylcholine29. The range of [Ca2+] 
rise rates had mean 5.3 μ M/s in 100 μ M ATP with range from cell to cell in 8 cells of 1–16 μ M/s. The 
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rise times indicated by the low affinity Furaptra were 1.9 ± 1.5 s. Similar large amplitude (6–35 μ M) fast 
(time to peak 0.8–2.7 s) transients were seen with acetylcholine with decay times of 1.6–9.1 s. GCaMP3fast 
responded with a faster 0.22 ± 0.08 s rise and a comparable 3.2 ± 0.4 s decay time in ATP stimulated 
HUVEC (Fig. 4d-g).
The basic considerations that go into choosing a Ca2+-indicator dye for a specific purpose include 
brightness, dynamic range, calibration, molecular targeting and resistance to bleaching. The flexibility 
in the design of genetically engineered probes provides the experimentalist with the option to choose 
a probe that meets specific needs, where speed and high Hill coefficient may be exactly what is needed 
in some situations, while brightness, linearity and sensitivity to small signals are the pre-requisites for 
addressing variations in baseline [Ca2+]. It is evident that the affinity and response kinetics of the probes 
are critical to optimum reporting. Firstly, the synthetic fluorescent Ca2+ probes have diffusion limited 
on kinetics in the range of ~5 × 108 M−1 s−1, and the commonly used Fluo-3 (kon = 7 × 108 M−1 s−1, 
koff = 370 s−1, Kd = 370 nM, n = 1)30 and Fura-2 (kon = 4 × 108 M−1 s−1, koff = 100 s−1, Kd = 260 nM, n = 1)30 
dyes. GCaMP-type GECI probes have more complex Ca2+ response kinetics in that they have a limiting 
rate of onset. Faster response kinetics by GCaMP3fast and GCaMP3bright were achieved by an increase 
in both the limiting rate of onset and the rate of decay. Secondly, having low Kd-s may often result in 
saturation, e.g. when the Ca2+ stores are fully released. Fast kinetics are achieved by increasing the Kd 
and consequently also the off-rate. However, when the Kd does not match the signal, e.g. Kd ≫ [Ca2+] 
peak, then the fluorescence dynamic range is reduced. Thirdly, the genetically engineered dyes can be 
targeted to specific proteins and therefore be used to probe micro-domains of Ca2+ that are of relevance 
for privileged communications between subcellular organelles. In this case speed and low affinity are 
both required (e.g. CalciumGreen-5N: kon = 2 × 108 M−1 s−1, koff = 9,000 s−1, Kd = 23 μ M, n = 1)30, since 
the local Ca2+ concentration may increase to tens or hundreds of μ M, but do so only briefly before being 
dissipated by diffusion.
Physiological [Ca2+] concentration ranges roughly fall into three groups: 100 nM to 1 μ M, 1 μ M to 
20 μ M (cytosolic) and 100 μ M to mM (subcellular organelles and extracellular matrix). Useful indicators 
(example probes in Supplementary Table S1) either have a Kd that is slightly higher than the range of 
interest (with a moderate dynamic range) or have a high enough Kd ([Ca2+] ~ × 10) (example probes in 
Supplementary Table S2) for linear response and suitable for quantification provided their fluorescence 
dynamic range is high enough to give a good signal at fractional saturation. GCaMP-type indicators most 
of which have a switch-like response indicate signals best at concentrations which are around their Kd. 
This is illustrated well in cardiac myocytes where GCaMP3fast and GCaMP3bright (Kd-s of 1–3 μ M) indicate 
0.5–1 μ M [Ca2+] with the greatest fidelity when compared with the high affinity GCaMP3, GCaMP6f and 
Fura-2 which distort the time course of Ca2+ signals due to saturation and slow equilibration (Figs 3 and 
4 and Supplementary Fig. S9). Although GCaMP6f and Fura-2 have fast enough Ca2+ on rates, the onset 
of the signal is similarly affected as for GCaMP3 which has a limiting response rate of 20 s−1. Faster off 
rates avoid prolonging buffering and studies with low affinity indicators reveal that even large Ca2+ tran-
sients are cleared at a high rate27,29. The benefit of faster off rates is clearly seen in the detection of local 
Ca2+ hotspots in cardiac myocytes on the 8–20 ms time scale (Supplementary Fig. S9).
Our kinetic characterisation revealed that the fluorescence response of GCaMPs to Ca2+ elevation is 
close to all-or-none at a limiting rate. The switch occurs around the Kd for Ca2+. With this type of indi-
cator, Ca2+ transients are counted rather than measured. The affinity-lowering mutations increased the 
limiting on rate as well as decay rate bringing the on rate into the low millisecond range.
We now discuss our findings regarding the kinetic mechanism of calmodulin-based GECI. Since the 
fluorescence of EGFP in effect reports the interaction of Ca2+.CaM with the RS20 peptide, it became 
possible to gain novel insights into the mechanism by which Ca2+.CaM recognizes and engages with its 
targets. First, the established cooperativity of Ca2+ binding is shown to be based on highly cooperative 
kinetics of Ca2+ association. Second, fluorescence onset occurs with a limiting maximum rate. Third, 
evidence for a partial CaM N-lobe only-attached peptide complex is shown by mGCaMP3 EF-3:4.
Apparently greater degrees of cooperativity beyond that predicted by the number of Ca2+ sites alone 
suggests that conformational changes associated with the peptide binding processes strengthen Ca2+ 
binding by the Ca2+.CaM.cpEGFP.RS20 mutant complexes. Dimerization could be a contributing factor. 
However it seems less likely as the mutations are not in the regions of the molecule, i.e. the cpEGFP 
domain, which are responsible for dimerization. Strikingly, saturating rates at high [Ca2+] are observed 
for all GECI proteins and their mutants providing evidence for the existence of conformational changes 
contributing to the degree of cooperativity and free energy coupling in Ca2+.CaM – target interactions. 
mGCaMP3 effectively switching between low and high fluorescence forms is in contrast with fluores-
cent indicators e.g. Fluo-3 the Ca2+ association rate of which is linearly dependent on [Ca2+]29 and the 
recently developed red Ca2+ indicator R-GCaMP2 which has reduced cooperativity (n = 1.2)31.
Interestingly, the limiting rates for GCaMP3 and GCaMP3bright show no temperature dependence 
in the 20 °C to 37 °C range. The GCaMP6f probe behaves the same way (N. Helassa and K. Török, 
unpublished data). The lack of temperature dependence suggests a diffusion limited binding process. As 
the Ca2+ binding rates are unlikely to be limiting, it may be that peptide binding within the GCaMP 
construct is sterically constrained, thus the limiting rate is set by the low frequency of collision. In con-
trast, GCaMP3fast displayed a 5-fold increase of the saturating rate over the same temperature range. By 
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contrast, dissociation rates of all the probes were greater at 37 °C than at 20 °C, an advantageous property 
for in vivo applications.
Taking advantage of our detailed measurements of Ca2+ association and dissociation kinetics, we 
developed a kinetic model to quantitatively account for the observed behaviour of GCaMP3fast (Fig. 1c). 
The model comprised the minimum number of steps required to take into account the Ca2+ binding 
properties of the CaM EF-3 mutant, its interactions with the RS20 target peptide and the processes 
that lead to restoration of fluorescence emission by cpEGFP4,19,20,32,33. Although Ca2+ association rate 
constants in the presence of a target peptide have not been determined, as a first approximation we used 
the same or similar rate constants as reported for Ca2+ binding to CaM32. A first intermediate had Ca2+ 
bound to the N-lobe sites and formed a partial complex (with relative fluorescence F1) by peptide binding 
to the P1 CaM binding site; a second intermediate (with relative fluorescence F2) formed by completing 
Ca2+ binding to the C-lobe site and peptide at the P2 site too. Postulation of two fluorescent conformers 
was based on the observation of biphasic Ca2+ association and dissociation kinetics for some mGCaMP 
and the requirement for functional N-lobe Ca2+ binding sites in CaM (EF-1 and EF-2) for fluorescence 
to develop.
Cooperativity was expressed by intrinsic rate constants in the model and was reflected by one or both 
fluorescent isomers being formed by essentially irreversible processes (Fig.  1c). The very small reverse 
rate constants determined in our best-fit analysis (Supplementary Table S3) were supported by exper-
imental evidence showing slow peptide dissociation at 0.0075 s−1 from the Ca2+.CaM.peptide complex 
with an RS20 analogue peptide (Trp peptide)19. As a consequence, peptide release rates were modelled 
to be determined by the Ca2+ dissociation rates from the Ca2+.CaM.cpEGFP.RS20 mutant complexes 
(Supplementary Fig. S13). As a further constraint, the overall Kd was kept close to the measured value. 
The same model is applicable to GCaMP3bright by omission of the red star signifying the RS-1 mutation 
(Fig. 1c). The model, appropriately taking into account the mutated sites, was applied to GCaMP3 and 
a selection of mGCaMP3 (Supplementary Materials, Supplementary Fig. S13, S14 and Supplementary 
Table S3) for which the kinetic data are overlaid with fitted curves (Fig.  2b,c,f,h, Supplementary Fig. 
S4–S6 and Supplementary Table S3).
The new data and interpretations presented here show that we have made a systematic and successful 
effort to improve the kinetics of biologically engineered calmodulin-based fluorescent peptide Ca2+ indi-
cators (GECI). This further suggests a strategy for improving the fluorescence and kinetic properties of 
GCaMP-type GECI. N-lobe CaM mutations are detrimental whereas C-lobe mutations improve or are 
neutral to /(+ ) (− )+ +F Fr Ca r Ca2 2 . Ca2+ kinetics are most markedly affected by combining mutations of the 
RS20 peptide and CaM EF-hands. The specific mutations carried out on GCaMP3 and derived GECI are 
applicable to the new generations of GECI e.g. GCaMP5, GCaMP6 and R-CaMP213,15,31 for generating 
fast-response variants. Two-photon absorption measurements show that recordings with deep penetra-
tion in GECI-expressing transgenic animals and tissues from these probes will be possible. Furthermore, 
the probes can be targeted to specific cell types, organelles and proteins using different promoters, tar-
geting sequences and binding domains. Thus, given the potentials and limitations of genetically 
engineered Ca2+ probes, a major hurdle has been overcome.
Methods
Materials. GCaMP6f, G-GECO 1.0 and GEM-GECO plasmids were purchased from Addgene (plas-
mid #40755, #32466 and #32463, respectively). pET41a and pEGFP-N1 vectors were obtained from 
Novagen and Clontech, respectively. XL10-Gold and BL21 (DE3) Gold cells were purchased from 
Invitrogen. Fluo-3 was purchased from Molecular Probes and EZ-Run protein ladder from Fisher 
Bioreagents. Restriction enzymes were obtained from New England Biolabs and T4 DNA ligase from 
Fermentas. Br2-BAPTA was purchased from Life Technologies.
Cloning of GECIs into bacterial GST-expression vector. The gcamp3 gene was subcloned by 
restriction-ligation from pUC57 into pET41a using BglII and NotI restriction enzymes and T4 DNA 
ligase following manufacturers’ protocols. The ggeco and gemgeco genes contained in pTorPE vectors11 
were subcloned into pET41a as described above except using NcoI and HindIII restriction sites. The 
resulting plasmids express GST-fused proteins.
Site-directed mutagenesis of GECIs. A series of DNA mutations were performed on pET41a-GCaMP3, 
pET41a-G-GECO and pET41a-GEM-GECO. Site-directed mutagenesis was carried out following the 
QuickChange II XL protocol (Agilent Technologies) to mutate the CaM EF-hands using the following 
primers (5′ →3′ ): EF-1, GCTTTCTCCCTATTTGCCAAGGACGGGGATGGG; EF-2, CATGATCAAT 
GAAGTAGCTGCCGACGGTAATGGC; EF-3, GCGTTCCGTGTGTTTGCTAAGGATGGCAATGGC; 
EF-4, GATCAGGGAAGCAGCCATCGATGGGGATGG; for the Trp →Tyr substitution in the RS20 pep-
tide sequence, primer RS-1 (5′ →3′ ), CGACTCATCACGTCGTAAGTACAATAAGACAGGTCACGCAG 
was used. Mutations were confirmed by DNA sequencing (Beckman Coulter Genomics).
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Expression and purification of GECI proteins. GCaMP3, G-GECO and GEM-GECO proteins were 
overexpressed in E. coli BL21(DE3) Gold cells. Cells were grown at 37 °C and expression was induced 
overnight at 20 °C in the presence of 0.5 mM isopropyl thio-β -D-galactoside (IPTG). Cells were resus-
pended in 50 mM Na+-HEPES, 200 mM NaCl, pH 7.5 containing one tablet of Complete protease inhibi-
tor cocktail (Roche, Basel, Switzerland). Cell lysis was performed by sonication on ice (VibraCell, Jencons 
PLS) and clarified lysates were purified by a single-step GST-chromatography (GSTrap, ÄKTA Purifier, 
GE Healthcare) at 4 °C. The column was equilibrated with 50 mM Na+-HEPES, 200 mM NaCl, pH 7.5. 
The purified protein was eluted in 50 mM Na+-HEPES, 200 mM NaCl, 10 mM reduced glutathione, pH 
7.5 and aliquoted fractions were stored at − 80 °C. Purity of the eluted fractions was determined by 
SDS-PAGE (gradient of 6.4%–20% acrylamide/bisacrylamide) and the identity of the GCaMP3, G-GECO 
and GEM-GECO proteins was confirmed by MALDI mass spectroscopy using sinapinic acid as a matrix 
(BruckerUltraFlex III, SGUL Biomics Centre).
Measurement of protein concentration. Mutant GCaMP3 proteins were highly purified 
(Supplementary Fig. S1), allowing protein concentration to be determined spectroscopically. The absorp-
tion spectra of all GECI and mGECI comprised three peaks at wavelengths 280 nm, 400 nm and 500 nm. 
Protein concentrations were determined with molar extinction coefficients (εo) at 280 nm calculated 
from the amino acid composition34 using a Nanodrop 1000 spectrophotometer (Thermo Scientific). The 
spectroscopically determined protein concentrations using the calculated ε o(280) were verified by parallel 
measurements using the Bradford assay35. We observed that the absorption ratio A280/A400 was affected 
by the mutations introduced. From the ε o(280) values and the A280/A400 ratios, the ε o(400) values were cal-
culated for each probe in a folded state at physiological pH rather than following protein denaturation11 
(Supplementary Table S4).
The stability of GCaMP3fast was tested at 37 °C by measurement of fluorescence emission over 4 h. 
Excitation wavelength was 492 nm.
The GST-tag that was introduced on the N terminus for purification purposes had no effect on the flu-
orescence properties. The Kd for Ca2+ of GST-GCaMP3 was 0.33 ± 0.01 μ M compared to 0.42 ± 0.06 μ M 
of GCaMP3 from which the GST-tag had been removed on the column by thrombin digestion 
(Supplementary Fig. S12).
Determination of free Ca2+ concentrations ([Ca2+]). [Ca2+] were calculated using the two-chelators 
Maxchelator program36 and verified by titrating Fluo-3 in 50 mM K+-HEPES, 100 mM KCl, 2 mM MgCl2, 
10 mM EGTA pH 7.5 as described below. Data were fitted to a one-site specific binding equation using 
Prism GraphPad 6 software, giving a dissociation constant for Fluo-3 for Ca2+ (Kd) of 326 ± 12 nM. 
Similar dissociation constant (Kd = 325 nM) has been reported by Molecular Probes. Fluo-3 was used as 
a reference compound to verify the calculated [Ca2+] of the solutions made for the stopped-flow exper-
iments of association kinetics (Supplementary Fig. S12).
Equilibrium Ca2+ binding. Ca2+ affinity assays of Fluo-3, GECI and mGECI were performed by con-
tinuous titration using an automated syringe pump (ALADDIN 1000, WPI). Fluo-3 or GECI proteins at 
50–100 nM concentration (50 mM K+-HEPES, 100 mM KCl, 2 mM MgCl2, 5 mM EGTA, pH 7.5 at 20 °C) 
were titrated with 325 mM CaCl2 at a 10 μ L/min flow rate in a stirred 3 mL cuvette. Fluorescence was 
measured at 492 nm excitation and 512 nm emission wavelengths using a Fluorolog3 spectrofluorimeter 
(Horiba Scientific). For mGCaMP3 RS-1 EF-hand mutants, Br2-BAPTA was used for Ca2+ buffering 
instead of EGTA. Fluorescence records were corrected for dilution and photobleaching. Data were nor-
malised and expressed as bound fraction and Ca2+ dissociation constant (Kd) and cooperativity (n) were 
obtained by fitting the data to the Hill equation using Prism GraphPad 6 software. All titrations were 
performed at least in triplicates and expressed as mean ± s.e.m.
Stopped-flow fluorimetry. Ca2+ association and dissociation kinetic experiments of GCaMP3, 
G-GECO and GEM-GECO proteins and of Fluo-3 were carried out on a Hi-Tech Scientific SF-61DX2 
stopped-flow system at 20 °C, unless specified otherwise. Fluorescence excitation was set to 492 nm for 
mGCaMP3 and mG-GECO, or 392 nm for mGEM-GECO. Fluorescence emission was collected using a 
530 nm cut-off filter. At least 3 replicates were averaged for analysis. Data were fitted to either a single or 
a double exponential to obtain the rise or decay rate using KinetAsyst software (TgK Scientific). As the 
“dead-time” of the instrument (time between the mixing and the point of observation) is ~1.5 ms, rates 
above 500 s−1 (t1/2 of 1.4 ms) cannot be accurately measured. To overcome this limitation, kinetics were 
measured at lower temperatures and the rates obtained by extrapolation from Arrhenius plots.
Association kinetics. The solution containing 1 μ M protein in 50 mM K+-HEPES, 100 mM KCl, 2 mM 
MgCl2, 10 mM EGTA pH 7.5 was rapidly mixed (1:1) with 50 mM K+-HEPES, 100 mM KCl, 2 mM 
MgCl2, 10 mM EGTA pH 7.5 containing increasing [Ca2+] concentrations (concentrations in the mixing 
chamber). For the determination of temperature dependence of Ca2+ association rates, protein samples at 
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1 μ M concentration were mixed as above to give a 20 μ M final [Ca2+] in the mixing chamber. The Ca2+ 
association rates to Fluo-3 were too fast to measure.
Dissociation kinetics. The solution containing 1 μ M protein in 50 mM K+-HEPES, 100 mM KCl, 2 mM 
MgCl2, pH 7.5 with saturating Ca2+ between 0.1–0.5 mM was rapidly mixed (1:1) with 50 mM K+-HEPES, 
100 mM KCl, 2 mM MgCl2, 10 mM EGTA pH 7.5 (concentrations in the mixing chamber). The Ca2+ dis-
sociation rate from Fluo-3 was measured using the same conditions.
Quantum yield determination. The concentration of GCaMP3 proteins was adjusted such that the 
absorbance at the excitation wavelength (490 nm) was between 0.001 and 0.1. A series of dilutions was 
prepared in a buffered solution (50 mM HEPES, pH 7.5, 100 mM KCl, 2 mM MgCl2 with either 5 mM 
EGTA or 1 mM CaCl2) and the fluorescence spectra were recorded on a Fluorolog3 (Horiba Scientific). 
GCaMP3 quantum yield measured in Ca2+-saturated buffer was used as a reference (Φ +Ca2+ = 0.4411). 
Data were plotted as integrated fluorescence intensity as a function of absorbance and fitted to a linear 
regression(S). Quantum yields were obtained using the following equation: Φ protein = Φ GCaMP3 × (Sprotein/
SGCaMP3).
pH sensitivity of GCaMP3 proteins. To determine the apparent pKa for each GCaMP3 proteins, a 
series of buffers were prepared. Depending on their respective pH buffering range, appropriate buffer 
was used for the measurements (MES for pH 6–6.5, HEPES for pH 7–8, TRIS for pH 8.5–9 and CAPS 
for pH 10). The pH titrations were performed by recording fluorescence spectra in Ca2+-free (50 mM 
buffer, 100 mM KCl, 2 mM MgCl2, 2 mM BAPTA) or Ca2+-saturated (50 mM buffer, 100 mM KCl, 2 mM 
MgCl2,1 mM CaCl2) using 1 μ M protein in 0.5 pH unit intervals (Fluorolog3, Horiba). BAPTA was cho-
sen as Ca2+ chelator because of its stable affinity for Ca2+ over the pH range.
Cloning of mGECIs into a mammalian expression vector. For expression in eukaryotic cells, 
the GCaMP3, G-GECO and GEM-GECO mutant DNAs were subcloned from pET41a into pEGFP-N1 
vectors by restriction-ligation using BglII and NotI restriction enzymes and T4 DNA ligase following 
manufacturer’s recommendations. During this process, the gfp initially present in the pEGFP-N1 vector 
was replaced by the gcamp3, ggeco or gem-geco gene.
Adenovirus generation. Adenoviruses (Ad5 backbone) expressing GCaMP3, GCaMP6f and 
GCaMP3fast under the control of the CMV promoter were obtained from Vector Biolabs (USA). Titer 
was estimated to be 5 × 1010 PFU/mL.
Neonatal cardiomyocyte (rN-CM) isolation. Rat neonatal CMs were isolated using an isolation kit 
from Worthington Biochemical Corporation (Lakewood, NJ 08701). One to three day-old neonatal rats 
were decapitated and the beating hearts were surgically removed and placed in chilled Hank’s Balanced 
Salt Solution (HBSS). The main vessels and atria were removed and the ventricles were minced with 
a razor blade to pieces < 1 mm3 that were incubated in HBSS with trypsin (50 μ g/mL) for 14–16 h at 
4 °C. The digestion was then arrested by exposure to trypsin inhibitor (200 μ g/mL) for 20 min in 37 °C. 
Thereafter collagenase (100 U/mL) was used for 30 min to isolate single rN-CM, which were filtered 
through a cell strainer and centrifuged at 1000 rpm for 3 min. Cells were re-suspended in Dulbecco’s 
Modified Eagle’s Medium (DMEM) containing 10% fetal bovine serum (FBS) with 1% penicillin/strepto-
mycin and 1% non-essential amino acids, plated on 100 mm dishes and placed in the incubator for 1–2 h 
to eliminate fibroblasts. Isolated single rN-CM were plated onto non-treated glass cover slips and used for 
adenovirus infection with Ad-GCaMP3, Ad-GCaMP6f or Ad-GCaMP3fast. After adenoviral infection of 
neonatal cardiomyocytes, the level of expression changes several-fold during 2–5 days of experimentation 
without significant changes in the time course of the measured fluorescence transients. Cells were used 
for confocal imaging and electrophysiology 48–72 h after viral infection. Although contraction artefacts 
are not particularly bothersome in short time cultured neonatal cardiomyocytes, they were suppressed 
by treating the cells with 10 μ M blebistatin.
Caffeine stimulation of cardiomyocytes. Rapid applications of 3 mM caffeine were used in the 
external K+-free solutions to probe the cellular Ca2+ stores or spontaneous Ca2+ release from sarcoplas-
mic reticulum.
Voltage clamp procedures on cardiomyocytes. Cells were voltage clamped in the whole-cell con-
figuration at − 50 mV to measure voltage dependent ICa using a Dagan amplifier and pClamp software 
(Clampex 10.2). In most experiments the membrane under the patch pipette was ruptured and the cells 
dialyzed with Ca2+-buffered pipette solutions containing 110 mM Cs+-aspartate, 5 mM NaCl, 20 mM 
TEA-Cl, 5 mM Mg2+-ATP, 0.1 mM EGTA 0.1 mM CaCl2, 10 mM glucose and 10 mM Cs+-HEPES pH 7.2. 
In some experiments the cells were examined with the perforated patch technique using pipette solutions 
containing 145 mM Cs+-glutamate, 9 mM NaCl, 1 mM MgCl2, 10 mM Cs+-HEPES pH 7.2 and 0.69 mg/mL 
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amphotericin B (Fisher Scientific). The extracellular solution used during experiments contained 137 mM 
NaCl, 5.4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose and 10 mM Na+-HEPES pH 7.4.
Two-dimensional confocal imaging. Cytosolic Ca2+, [Ca2+]i, was measured simultaneously with 
the patch clamp or independently using a Noran Odyssey XL rapid two-dimensional laser scanning con-
focal microscopy system (Noran Instruments, Madison, WI, USA) attached to a Zeiss Axiovert TV135 
inverted microscope fitted with an × 63 water-immersion objective lens. The excitation wavelength of 
the argon ion laser was set to 488 nm, and fluorescence emission was measured at wavelengths > 515 nm. 
Cells were imaged confocally at 30–120 frames/s depending on the experimental requirement. To reduce 
photobleaching, the laser beam was electronically shuttered and triggered to open on command by the 
pClamp program only during acquisition of data. Images were filtered by 2 × 2 pixel-averaging. Results 
are presented as whole-cell measurements by integrating the fluorescence response from an entire cell 
(Fig.  3), or as local responses from regions of interest (ROI), as detailed in legend for Supplementary 
Fig. S9. The amplitudes of the Ca2+-dependent cellular fluorescence signals were quantified as Δ F/F0. 
Experiments were carried out at room temperature (22–24 °C).
Cell culture, transfection and live cell imaging of Fura-2 and GCaMP fluorescence in human 
umbilical vein endothelial cells. HUVEC were grown and transfected as previously described37,38. 
For live cell imaging Nucleofected HUVEC were seeded onto 35 mm diameter poly-D-lysine coated glass 
bottomed culture dishes (MatTeK, Ashland, MA) and used 24 h post Nucleofection. Cells were trans-
ferred to physiological saline solution (140 mM NaCl, 5 mM KCl, 1.8 mM CaCl2, 10 mM glucose, 10 mM 
Na+-HEPES pH 7.4) and placed on the stage of an inverted Olympus IX71 fluorescence microscope. The 
microscope was equipped with an Olympus UPLSAPO × 100 1.40 NA objective and an OptoLED light 
source (Cairn Research, Faversham, UK) for fast epifluorescence illumination of Fura-2 (355 ± 10 nm 
and 380 ± 11 nm) and EGFP (470 ± 20 nm) fluorescence. Excitation light was directed to the specimen 
via a 500DCXR dichroic mirror (Chroma Rockingham, USA) and emitted light collected through a 
535 ± 30 nm emission filter onto an Ixon3 EMCCD camera (Andor, Belfast, UK) operated in frame 
transfer mode at full gain and cooled to − 68 °C. Images were acquired at 30 frames/s using Winfluor 
software (http://spider.science.strath.ac.uk).
Fura-2 loading was performed under conditions where it had previously been established that no 
perturbation of stimulated exocytosis, a particularly sensitive Ca2+-dependent cell output, of fluorescent 
secretory granules occurred37,38. For stimulation GCaMPfast-expressing cells with low expression levels 
(low intrinsic levels of resting fluorescence) were chosen to minimise the effect of buffering, and the 
time courses for GCaMPfast signals were similar with or without simultaneous Fura-2 loading. Arbitrary 
units of fluorescence were used as Fura-2 calibration is not meaningful due to the saturating levels of 
[Ca2+] rise.
To determine the dynamic range of mGECI, cells were stimulated using ionomycin (2 μ M) to increase 
intracellular free [Ca2+] to high levels. For physiological studies cells were stimulated with the extracel-
lular hormone ATP (2 μ M). Drug application was by pressure injection from a glass pipette (Warner 
instruments, Kent, UK) at ~2 p.s.i. positioned close to the cell as previously described38. Image analysis 
was carried out in Winfluor. Dataset plotting, fitting and analysis were performed in Microcal Origin 7.5 
(OriginLab Corporation, Northampton, MA). Results are expressed as mean ± s.e.m. unless indicated 
otherwise.
To determine the time course for cytoplasmic Rura-2 and/or GCaMP fluorescence changes during 
ATP stimulation a rectangular region of interest (ROI) was placed over a peripheral region of each cell, 
excluding the nucleus and immediate perinuclear region. The mean background fluorescence was meas-
ured by ROI with the same dimensions placed at a point at which no cell was present. GCaMP fluores-
cence changes were obtained from the background-subtracted fluorescence at 470 nm excitation within 
the WinFluor program. Fura-2 ratio changes were calculated by dividing the background-subtracted 
fluorescence at 355 nm by that at 380 nm in WinFluor. The ratio of the resulting background-subtracted 
fluorescence signals at 355 nm and 380 nm were taken to represent the change in [Ca2+]i, as previously 
described38.
Cell culture, transfection and live cell imaging of Fura-2 and GCaMP fluorescence in HEK293T 
cells. HEK293T cells were grown on a 100 mm × 20 mm culture dish in DMEM supplemented with 
10% fetal bovine serum and 1% Penicillin-Streptomycin solution. At 90% confluence cells were plated on 
to glass coverslips (12 mm diameter) in 35 × 10 mm petri dishes. Transfection was accomplished using 
Lipofectamine™ 2000 (Invitrogen): 0.5 μ g of plasmid DNA was combined with 8 μ L Lipofectamine™ 2000 
reagent in 200 μ L Opti-MEM, this was then added to the cell culture medium. The transfection medium 
was removed after 8–10 hours and experiments were performed 48 hours after transfection.
Transfected HEK293T cells were loaded with 1 μ M Fura-2 AM (Molecular Probes, Eugene, OR, USA) 
for 20 minutes at 37 °C, and then incubated in dye-free solution for at least 20 minutes before begin-
ning experiments to allow for the de-esterification. Cells were mounted on the stage of an inverted 
Nikon microscope with a × 40 oil-immersion objective and perfused with a Tyrode’s solution at 37 ± 2 °C 
(137 mM NaCl, 10 mM HEPES, 10 mM D-glucose, 5.4 mM KCl, 2 mM CaCl2, 1 mM MgCl2). Ca2+ release 
in HEK293T cells was induced by a 5 s pulse of 100 μ M ATP produced by a digitally triggered solution 
www.nature.com/scientificreports/
1 4Scientific RepoRts | 5:15978 | DOi: 10.1038/srep15978
‘puffer’ positioned ~250 μ m away from cell. A rapid (1.2 kHz) scanning dual beam excitation fluores-
cence photometry apparatus (Vibraspec Inc., Bear Island, ME, USA) was used to simultaneously monitor 
whole-cell response to changes in [Ca2+] by Fura-2 and GCaMP3 or mGCaMP3 by employing alternat-
ing 380/25 and 488/20 nm wavelengths, respectively39.
Measurement of two-photon cross-sections. Two-photon absorption (TPA) or two-photon 
cross-section (σ 2) is the absorption coefficient for the simultaneous absorption of two photons for the 
excitation of a fluorophore. TPA becomes relevant at high light intensities and as it is generated by 
the sum of the energies of two photons, it occurs at approximately double of the wavelength at which 
one photon excitation would have occurred. The two-photon fluorescence cross-sections of GCaMP3, 
G-GECO, GEM-GECO and their mutants were typically measured at 940 nm (unless specified other-
wise) in 50 mM K+-HEPES, 200 mM NaCl, pH 7.5, 10 mM reduced glutathione at high Ca2+ (200 μ M) 
or low Ca2+ (2 mM EGTA). Measurements were made in a 50 μ L quartz cuvette with 3 mm path length. 
Excitation was with femtosecond-pulsed light from a tuneable TiS laser (710–990 nm, 100–150 fs pulses 
80 MHz; MaiTaiBB, Spectra Physics) focused into the cuvette with a 50 mm f.l. achromatic doublet after 
3× expansion. Average power was monitored after the cuvette. Fluorescence was measured normal to the 
excitation path through a band pass filter (Chroma ET525/50-2P) with a photodiode and I/V amplifier. A 
reference spectrum for fluorescein (20 μ M in 10 mM Na+-borate buffer pH 11) was determined in each 
run. After subtraction of background, fluorescence cross-sections were calculated for Ca2+-saturated and 
Ca2+-free protein with reference to the published values for fluorescein23.
Data analysis, statistics and kinetic modelling. Biophysical experiments were performed at least 
in triplicates and analysed using GraphPad Prism and KinetAsyst (tgk Scientific) software. Cardiac myo-
cytes, HUVEC and HEK293T cell experiments were carried out on three independent preparations each. 
The total number of cells analysed in each condition is given in the figure legends. Significance level was 
obtained using the one-way ANOVA test with multiple comparisons. P values in the figures are repre-
sented by stars (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001). Kinetic modelling was performed 
using DynaFit4 software according to the scheme presented in Supplementary Fig. S14.
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Supplementary Materials 
 
Fluorescence properties of mGCaMP3, mG-GECO and mGEM-GECO probes  
   mGCaMP3 EF-3, mGCaMP3 EF-3:4, mGCaMP3 RS-1 and mGCaMP3 RS-1 EF-4 had 
similar biophysical characteristics to GCaMP3fast  and GCaMP3bright (Supplementary Table 
S1). Mutation of G-GECO and GEM-GECO generally resulted in faster Ca
2+
 response 
kinetics, however mG-GECO and mGEM-GECO remained considerably slower than 
mGCaMP3. 
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  The affinity measured for G-GECO (Kd of 630 nM) was decreased for both of mG-GECO 
EF-3 and mG-GECO EF-4 (Kd of 1.3 and 1.7 M, respectively). They retained the ~2-fold 
greater Fr(+Ca2+) / Fr(-Ca2+) of G-GECO than that for GCaMP3 in vitro and were comparable to 
GCaMP3 in HUVEC. Thus, mG-GECO EF-3 and mG-GECO EF-4 may be suitable for 
cellular Ca
2+
 tracking. Under two-photon excitation, mG-GECO EF-1, mG-GECO EF-3 and 
mG-GECO EF-4 had 2 (+Ca
2+
) /2 (-Ca
2+
) ratios of 26-, 7- and 13-fold, respectively, 
greatly increased from 3-fold for G-GECO (Supplementary Fig. S11, Supplementary 
Tables S1, S2).  Interestingly, mG-GECO EF-2:3 having an outstanding 1.8 mM Kd (and 
none in the M range) for Ca2+ may be suitable for measuring extracellular Ca2+ 
concentrations (Supplementary Fig. S3, Supplementary Table S2).  
  mGEM-GECO EF-1, EF-3 and EF-4 had similar ratiometric fluorescence dynamic ranges. 
mGEM-GECO EF-3 had the highest ratiometric fluorescence dynamic range ((F(+Ca
2+
) /F(-
Ca
2+
))exc 492 /(F(+Ca
2+
) /F(-Ca
2+
))exc 392 of 108, with the mGEM-GECO EF-4 ((F(+Ca
2+
) /F(-Ca
2+
))exc 
492 /(F(+Ca
2+
) /F(-Ca
2+
))exc 392 of 92) and EF-1 mutants following closely ((F(+Ca
2+
) /F(-Ca
2+
))exc 492 
/(F(+Ca
2+
) /F(-Ca
2+
))exc 392 of 96). The EF-1:2 mutation in mGEM-GECO, as in mGCaMP3 and 
mG-GECO, led to no detectable response to Ca
2+
 binding. In terms of kinetics, mGEM-
GECO EF-2:4 had a Ca
2+
 dissociation rate of 8.3 s
-1
,
 
~ 100-fold faster than GEM-GECO for 
which koff was 0.08 s
-1
 at 20 
o
C. (Supplementary Fig. S5 and Supplementary Table S1, 
S2). Although the Ca
2+
 decay kinetics of mGEM-GECO EF-2:4 are much slower than those 
of GCaMP3fast, given their ratiometric fluorescence properties, GEM-GECO mutants may 
become useful for quantitative measurements of Ca
2+
 transients that occur on the scale of 
seconds
18
. 2 (+Ca
2+
)/2 (-Ca
2+
) ratios in the 2- to 9-fold range of mGEM-GECO EF-1, EF-2 
and EF-4 suggest their likely suitability for two-photon microscopy (Supplementary Fig. 
S11 and Supplementary Tables S1, S2). 
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Modelling the kinetics of Ca
2+
-induced fluorescence changes of mGCaMP 
  The model (Fig. 1c, Supplementary Fig. S13, S14 and Supplementary Table S3) was 
constrained in the following ways: Kd was estimated as the root of the product of the Kd 
values for each step by the measured Hill coefficient giving Kd overall = 
n√(Kd1 * Kd2…). 
Although Ca
2+
 dissociation does not follow the reverse association pathway, constrains are 
offered by parameters of the isomerisations linking the two fluorescent conformers (see 
Supplementary Fig. S14). Previously determined rate constants for Ca
2+ 
association for CaM 
were used
32
. Association kinetic data were simultaneously fitted to records obtained for a 
series of [Ca
2+
].  
  The model has a number of limitations at present. It was necessary to put forward an 8-step 
model, however, the observed association and dissociation processes were at most biphasic. 
Although rate constants were available for Ca
2+
 binding to CaM
26
, there is currently no 
evidence to show that they remain the same in the presence of target peptide. Given the 
accuracy of [Ca
2+
] measurements, fitted [Ca
2+
] concentrations in the nM range were accepted 
within ± 15% of those measured. The equilibrium of protonated dark and unprotonated 
fluorescent forms is not known, thus the protein concentration estimate and the associated Fr 
values were floated to be best fit. At present there is no physical evidence for the fitted rates 
and it is thus not possible to predict the effect of mutations on specific kinetic constants. This 
is underlined by the lack of a clear pattern in the assignation of large or small rate constants 
to specific processes of the model. For example, while the rate constant for the dissociation of 
Ca
2+
 bound to EF-hand 1, k-2 was best fit with values > 1000 s
-1
 for GCaMP3 and the EF-3 
and EF-4 mutants, the same process was fit with values < 5 s
-1 
for
 
the EF-3:4 and the RS-1 
mutants. To comply with the constraint of the Kd values, this reduction was counterweighted 
by an appropriately greater value for dissociation rate constant, k-2, of the first peptide 
binding event (for further detail, see Footnote for Supplementary Table S3). These 
limitations may be overcome by further resolving specific processes.  
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Supplementary Figure S1. Purity and stability of GCaMP3 and mGCaMP3. (a) Typical 
Coomassie Brilliant Blue-stained gradient SDS-PAGE analysis of GCaMP3, following GST 
chromatography. Lane 1: EZ-Run protein ladder, Lane 2-4: 30 g, 15 g and 3 g of 
GCaMP3 from eluted fractions, respectively. (b) Stability of GCaMP3fast at 37 
o
C. 
GCaMP3fast was incubated at 37 
o
C and fluorescence emission spectra of the samples were 
recorded at 0 h (▬), 1 h (▬) and 4 h (▬). Excitation was at 492 nm. Dashed lines show 
sample in low Ca
2+
 and solid lines represent sample in high Ca
2+
.   
5 
 
 
 
Supplementary Figure S2. pH sensitivity and pKa determination of (a) GCaMP3; (b) 
GCaMP3fast  and (c) GCaMP3bright. Normalised fluorescence in the presence of 1 mM Ca
2+
 (■) 
and in 2 mM BAPTA (●); F/F0 (▲).
6 
 
 
Supplementary Figure S3. Equilibrium Ca
2+
 titrations of mGECIs. (a) mGCaMP3 EF-1 (▼), EF-2 (●) and EF-3 (■); (b) mGCaMP3 EF-1:3 (■), EF-
1:4 (▲), EF-2:3 (▼), EF-2:4 (♦) and EF-3:4 (●); (c) mGCaMP3 RS-1 (■), RS-1 EF-1 (▼), RS-1 EF-2 (●) and RS-1 EF-4 (▲); (d) mGCaMP3 RS-1 
EF-1:2 (♦), RS-1 EF-1:3 (■), RS-1 EF-1:4 (▲), RS-1 EF-2:3 (▼), RS-1 EF-2:4 (♦) and EF-3:4 (●); (e) G-GECO (●), mG-GECO EF-1 (▼), EF-2 (●), 
EF-3 (■) and EF-4 (▲); (f) GEM-GECO (●), mG-GECO EF-1:3 (■), EF-1:4 (▲), EF-2:3 (▼), EF-2:4 (♦) and EF-3:4 (●);  (g) mGEM-GECO EF-1 
(▼), EF-2 (●), EF-3 (■) and EF-4 (▲); (h) mGEM-GECO EF-1:3 (■), EF-1:4 (▲), EF-2:3 (▼) and EF-2:4 (♦). Fluorescence changes are normalised to 
F0 of 0 and Fmax of 1 and fitted to the Hill equation. Fitted curves are represented by solid lines overlaying the data.
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Supplementary Figure S4. Ca
2+ 
association and dissociation kinetics with a schematic 
model of the kinetic mechanism of GCaMP3. (a) Association kinetic records were taken at 
varied final [Ca
2+
]. Fluorescence changes are normalised to F0 of 0 and maximum of 1. 
Experimental data are represented by dotted lines, final [Ca
2+
] is given in brackets: (···) (190 
nM), (···) (550 nM), (···) (780 nM), (···) (1.8 M), (···) (2.6 M), (···) (3 M), (···) (10 M) 
and (···) (20 M). Corresponding solid lines are the fitted curves using parameters shown in 
Supplementary Table S3 fitted to the scheme in Supplementary Fig. S12. (b) Plot of 
observed rates of Ca
2+
 association with GCaMP3 as a function of final [Ca
2+
]. (c) 
Dissociation kinetic record of GCaMP3 (···). Fluorescence intensities are relative to the Ca
2+
-
bound form. The solid line (▬) represents the fitted curve with parameters shown 
Supplementary Table S3.
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Supplementary Figure S5. Dissociation kinetics for Ca
2+
 of (a) mGCaMP3 EF-1 (▬), EF-2 (▬) and EF-3 (▬), overlaid by fitted curve using 
parameters shown in Supplementary Table S3; (b) EF-1:3 (▬), EF-1:4 (▬), EF-2:3 (▬), EF-2:4 (▬) and EF-3:4 (▬), overlaid by fitted curve using 
parameters shown in Supplementary Table S3; (c) mGCaMP3 RS-1  (▬), RS-1 EF-1 (▬), RS-1 EF-2 (▬) and RS-1 EF-4 (▬), overlaid by fitted 
curve using parameters shown in Supplementary Table S3; (d) mGCaMP3 RS-1  EF-1:3 (▬), RS-1  EF-1:4 (▬), RS-1  EF-2:3 (▬),   RS-1  EF-2:4 
(▬) and  RS-1 EF-3:4 (▬). Fluorescence intensities are relative to Ca2+-bound GCaMP3. (e) G-GECO (▬),   mG-GECO EF-1 (▬), EF-2 (▬),  EF-3 
(▬) and  EF-4 (▬),  (f) mG-GECO EF-1:4 (▬), EF-2:3 (▬), EF-2:4 (▬) and EF-3:4 (▬). Fluorescence intensities are relative to Ca2+-bound G-
GECO. (g) GEM-GECO, (▬); mGEM-GECO EF-1 (▬), EF-2 (▬), EF-3 (▬) and EF-4 (▬); (h) mGEM-GECO EF-1:2 (▬), EF-1:3 (▬), EF-1:4 (▬), 
EF-2:3 (▬), EF-2:4 (▬) and EF-3:4 (▬). Fluorescence intensities are relative to Ca2+-bound GEM-GECO.
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Supplementary Figure S6. Association kinetics for Ca
2+
 of (a) mGCaMP3 EF-1, (b) mGCaMP3 EF-2, 
(c) mGCaMP3 EF-3, overlaid by fitted curve using parameters shown in Supplementary Table S3, (d) 
mGCaMP3 EF-1:4, (e) mGCaMP3 EF-2:3, (f) mGCaMP3 EF-2:4, (g) mGCaMP3 EF-3:4, (h) mGCaMP3 
RS-1 and (i) mGCaMP3 RS-1 EF-4, (g-i) experimental records are overlaid with fitted curves using 
parameters shown in Supplementary Table S3. Left panels show plots of the [Ca
2+
] dependence of the 
observed rate(s) (kobs), right panels show stopped-flow records at the specified final [Ca
2+
]. Fluorescence 
changes are normalised to F0 of 0 and maximum of 1.  For mGCaMP3 with biphasic association kinetics, 
the slow and the fast components are represented in red and black, respectively.  
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Supplementary Figure S7. Association kinetics for Ca
2+
 of (a) G-GECO, (b) mG-GECO EF-1, (c) mG-
GECO EF-2, (d) mG-GECO EF-3, (e) mG-GECO EF-4, (f) mG-GECO EF-1:4, (g) mG-GECO EF-2:3, 
(h) mG-GECO EF-2:4 and (i) mG-GECO EF-3:4 Left panels show plots of the [Ca
2+
] dependence of the 
observed rate(s) (kobs), right panels show stopped-flow records at the specified final [Ca
2+
]. Fluorescence 
changes are normalised to F0 of 0 and maximum of 1. For mG-GECOs with biphasic association kinetics, 
the slow and the fast components are represented in red and black, respectively.  
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Supplementary Figure S8. Association kinetics for Ca
2+
 of (a) GEM-GECO, (b) mGEM-GECO EF-1, 
(c) mGEM-GECO EF-2, (d) mGEM-GECO EF-3, (e) mGEM-GECO EF-4, (f) mGEM-GECO EF-1:2, 
(g) mGEM-GECO EF-1:3, (h) mGEM-GECO EF-1:4, (i) mGEM-GECO EF-2:3, (j) mGEM-GECO EF-
2:4, (k) mGEM-GECO EF-3:4. Left panels show plots of the [Ca
2+
] dependence of the observed rate(s) 
(kobs), right panels show stopped-flow records at the specified final [Ca
2+
]. Fluorescence changes are 
normalised to F0 of 0 and maximum of 1. For mGEM-GECOs with biphasic association kinetics, the slow 
and the fast components are represented in red and black, respectively.  
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Supplementary Figure S9. Measurement of perinuclear Ca
2+
 hotspots with GCaMP3fast in a 
spontaneously pacing rat neonatal cardiomyocyte.  The images show the baseline fluorescence (F0), 
regions of interest (ROI), and two sequences of 5 frames (F) measured at 120 Hz at the onset of two 
beats (a-e and f-j) at the times indicated along the traces showing intensity changes around the nucleus 
(▬) and in the cytosol in general (▬).  Arrows in the 1, 4, and 7 ‘o’clock’ directions point to prominent 
Ca
2+
 release sites that are visible in consecutive frames and/or beats. Some local hotspots e.g. that pointed 
at by the 7 ‘o’clock’ direction appear in 8.3 ms from one frame to the next and then fade away in ~20 ms 
after 1 or 2 additional frames. NOTE: similar time courses of local Ca
2+
 hot spots are recorded with 
GCaMP3bright too (data not shown). 
  ROI were chosen by first inspecting individual frames (insets a-j) and selecting localities where early 
release was (red) or was not (orange) apparent by F. The time course of fluorescence changes in 
multiple points was then observed as F/F0 which in the orange ROI remained low and therefore 
nowhere required special attention in the form of additional localized ROIs.  Based on dimensions, the 
general morphology of neonatal cardiomyocytes, F0-distribution, and bright field images, the red region is 
described as being “perinuclear”.  A transition region between the red and the orange ROI was omitted 
for clarity.
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Supplementary Figure S10. Characterisation of selected mGCaMP3 probes in HEK293T cells where 
Ca2+ transients were triggered by exposure to 100 µM ATP for 5 s. (a-c) Representative fluorescence 
recordings (arbitrary units) measured with Fura-2 (▬) simultaneously with (a) GCaMP3 (▬), (b) 
GCaMP3fast (▬) or (c) GCaMP3bright (▬).  Insets show comparison of normalized fluorescence 
responses. (d-f) Comparison of the average fluorescence responses of the four Ca2+ probes. (d) 
Fluorescence rise-times of Ca
2+
 for Fura-2 (▬) (n = 30), GCaMP3 (▬) (n = 10), GCaMP3fast (▬) (n = 
10) and GCaMP3bright (▬) (n = 10) after ATP stimulation; (e) Fluorescence decay times (measured from 
peak to 30% peak amplitude) of Ca
2+
 for Fura-2 (▬) (n = 23), GCaMP3 (▬) (n = 10), GCaMP3fast (▬) (n 
= 9) and GCaMP3bright (▬) (n = 9) after ATP stimulation; (f) F/F0 for the four Ca
2+
 probes, colour-coded 
as in (a-c). (g) In vitro Kd values (from Table 1 and Kd for Fura-2 of 260 nM
30
). 
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Supplementary Figure S11. Two-photon excitation spectra of mGECIs. (a) mGCaMP3 EF-1 (▼) and EF-2 (●) and mGCaMP3 EF-3 (■); (b) mGCaMP3 
EF-1:4 (▲), EF-2:3 (▼), EF-2:4 (♦) and EF-3:4 (●); (c) mGCaMP3 RS-1 EF-1 (▼), RS-1 EF-2 (●) and RS-1 EF-4 (■); (d) mGCaMP3 RS-1 EF-1:2 (▼), 
RS-1 EF-1:3 (■), RS-1 EF-2:4 (♦) and RS-1 EF-3:4 (●); (e) G-GECO (●), mG-GECO EF-1 (▼), EF-3 (■) and EF-4 (▲); (f) mGEM-GECO (●), mGEM-
GECO EF-1 (▼), EF-2 (●) and EF-4 (▲); (g) mGEM-GECO EF-1:4 (▲), EF-2:3(▼) and EF-2:4 (♦). Solid lines show spectra in the presence and dotted 
lines in the absence of Ca
2+
.
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Supplementary Figure S12. Verification of [Ca
2+
] with Fluo-3 of GST-tagged and untagged GCaMP3. 
(a) Fluo-3 titration was carried out as described in Methods. A Kd value of 329 ± 12 nM was obtained by 
fitting the data to a single site binding model. (b) Equilibrium Ca
2+
 binding of GST-tagged GCaMP3 (●) 
and GST-cleaved GCaMP3 (▲) were compared. Kd values of 0.42 ± 0.04 M and 0.33 ± 0.01 M and 
Hill coefficients of 2.8 and 3.2 were obtained, respectively.  (c) Fluo-3 titration curve obtained by 
measuring Fluo-3 fluorescence in a series of solutions made for stopped-flow association kinetics of 
varied final [Ca
2+
] as a means of verification of the calculated final [Ca
2+
]. A Kd value of 314 ± 39 nM 
was obtained, not significantly different from that obtained in continuous titration experiments (see (a)). 
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Supplementary Figure S13. Schematic model of the kinetic mechanism of GCaMP3. General model for 
the mechanism of Ca
2+
-induced fluorescence of GCaMP3 depicting Ca
2+
 binding to the CaM N- and C-
lobe followed by peptide binding and isomerisation leading to fluorescent states. Fluorescence is 
proposed to derive from the equilibrium of two states: in the first, Ca
2+
-bound CaM N-lobe is with the P1 
CaM binding site of RS20; in the second, both the N- and C-lobes of CaM are Ca
2+
-bound binding to both 
the P1 and P2 sites of the peptide. Formation of the fluorescent complexes involves essentially 
irreversible processes. Peptide release is triggered by Ca
2+
 sequestration returning the complex to the apo-
state. This general model is applied to EF-hand mutants of GCaMP3 by omitting the appropriate Ca
2+
 
binding steps e.g. equation (1) (Supplementary Fig. S14) for the EF-1 mutant, equation (2) for EF-2 and 
so on.  
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Supplementary Figure S14. Detailed kinetic model of Ca
2+
-induced fluorescence of GCaMP3. 
Equations (1) & (2) are shown as single step in Supplementary Fig. S13; equation (3) represents an 
intramolecular reaction; equation (4) describes a process in which a fluorescence increase occurs; 
equations (5) & (6) are shown as single step in Supplementary Fig. S13; equation (7) represents an 
intramolecular reaction; equation (8) describes a process in which a fluorescence increase occurs; Note 
that peptide release can occur reversibly in steps (4) & (7). 
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Supplementary Table S1. Summary of the biophysical characteristics and cellular fluorescence 
properties of selected mGECIs. Fluorescence enhancement expressed as the ratio of fluorescence 
intensities in the presence and absence of Ca
2+ 
(F(+Ca2+) / F(-Ca2+)), Kd and Hill coefficient (n) were obtained 
from the equilibrium calcium binding titrations at 20 °C. Maximal fluorescence rise (kon(lim)) and decay 
(koff) rates were obtained from the association and dissociation stopped-flow kinetics at 20 °C. The 
cellular fluorescence dynamic range (F/F0) values were obtained from fluorescence measurements in 
HUVEC cells during acute exposure to ionomycin and HEK293T cells after ATP stimulation. Two-
photon cross-section values in the presence and absence of Ca
2+
 were obtained from the two-photon 
spectra at 940 nm unless otherwise specified, using fluorescein as a reference. 
a
Recorded at 920 nm. 
b
Recorded at 820 nm. 
c
Biphasic association kinetic records were fitted with two exponentials. The rate of 
each phase is given with the relative amplitudes in parentheses. 
d
Measurements were made at 20, 25 and 
30 
o
C. Rates were too fast to measure at 37 
o
C, thus value was extrapolated from Arrhenius plot. 
e
Ratiometric  (F(+Ca2+) /F(-Ca2+))exc 492 /(F(+Ca2+) /F(-Ca2+))exc 392. 
f
Recorded at 930 nm. n.d. stands for not 
determined. 
20 °C 37 °C 20 °C 37 °C  - Ca2+  + Ca2+
GCaMP3 6.3 0.33 ± 0.01 3.2 ± 0.1 20 ± 1 19 ± 1 1.5 ± 0.1 5.3 ± 1 0.06f 0.76f 5.6 2.5 ± 0.4
GCaMP3fast 8.8 2.8 ± 0.3 4.3 ± 0.2 145 ± 2 743
d 62 ± 2 210 ± 6 0.10 0.47 3.4 0.2 ± 0.04
135 ± 8 (0.5) 139 ± 41 (0.5)
19 ± 1 (0.5) 26 ± 2 (0.5)
148 ± 14 (0.5) 155 ± 55 (0.5)
24 ± 1 (0.5) 27 ± 3 (0.5)
mGCaMP3 EF-3:4 2.6 ± 0.2 2.4 ± 0.1 2.8 ± 0.2 141 ± 6 235d 99 ± 1 283 ± 10 0.21 0.69 3.9 0.1 ± 0.03
mGCaMP3 RS-1 10.4 ± 0.2 0.95 ± 0.01 3.4 ± 0.1 67 ± 1 105 ± 2 2.5 14.4 ± 0.4 n.d. n.d. n.d. n.d.
86 ± 2 (0.6)
30 ± 2 (0.4)
G-GECO 12.7 ± 0.1 0.63 ± 0.01 3.3 ± 0.1 8.3 ± 0.1 n.d. 1.8 ± 0.1 n.d. 0.16 0.50 11.2 n.d.
44 ± 1 (0.5)
6.7 ± 0.1 (0.5)
26 ± 2 (0.3)
6.0 ± 0.2 (0.7)
33 ± 3 (0.3)
1.0 ± 0.1 (0.7)
7.1 ± 0.4 (0.5)
1.3 ± 0.1 (0.5)
15 ± 1 (0.3)
0.9 ± 0.1 (0.7)
F /F 0 
(HEK293T)
1.3 ± 0.1
0.4 ± 0.1
n.d.
n.d.
n.d.
mGEM-GECO EF-1
n.d.
n.d.
n.d.0.68b
96 ± 5e 0.65 ± 0.01 2.2 ± 0.1 n.d. 0.30 ± 0.01 n.d.
n.d. n.d.3.3 ± 0.1
0.17 1.15
5.4 ± 0.1
1.7 ± 0.1
0.08 ± 0.01 n.d.
0.39b
n.d.
6.7
0.13 1.67 4.5
n.d.1.13a 0.13a
1.21b 0.45b
189 ± 10 302 ± 3
mG-GECO EF-4 14.2 ± 1.0 1.7 ± 0.1 2.7 ± 0.2 n.d.
mG-GECO  EF-3 12.4 ± 0.4 1.3 ± 0.1 2.7 ± 0.1 n.d.n.d.
n.d.
66 ± 1
6.7
mGCaMP3 RS-1 EF-4 11.1 ± 0.3 5.6 ± 0.1 3.8 ± 0.1 0.08 0.55 3.9
3.1 ± 0.1 0.23 1.52mGCaMP3 EF-3 7.2 ± 0.2 0.50 ± 0.01 4.2 ± 0.1 12 ± 1
F /F 0 
(HUVEC)
Protein
F (+Ca
2+
) /     
F (-Ca
2+
)
Kd (M) n
2                                           
(10-50 cm4 x s x photon-1)
k on(lim)
c            
 (s-1)
k off
c
 (s-1)
n.d.
41 ±3e
GEM-GECO 107 ± 2e 0.13 ± 0.01 3.6 ± 0.1
1.8 ± 0.1 2.0 ± 0.1mGEM-GECO EF-2
GCaMP3bright 14 0.93 ± 0.01 4.7 ± 0.1 2.8 ± 0.1 15 ± 0.2 0.22 2.00 5.6 0.6 ± 0.1
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Supplementary Table S2. Summary of the biophysical characteristics and cellular fluorescence 
properties of other mGECIs. Fluorescence enhancement expressed as the ratio of fluorescence 
intensities in the presence and absence of Ca
2+ 
(F(+Ca2+) / F(-Ca2+)), Kd and Hill coefficient (n) were obtained 
from the equilibrium calcium binding titrations at 20 °C. Maximal fluorescence rise (kon(lim)) and decay 
(koff) rates were obtained from the association and dissociation stopped-flow kinetics at 20 °C. The 
cellular fluorescence dynamic range (F/F0) values were obtained from fluorescence measurements in 
HUVEC cells during acute exposure to ionomycin and HEK293T cells after ATP stimulation. Two-
photon cross-section values in the presence and absence of Ca
2+
 were obtained from the two-photon 
spectra at 940 nm unless otherwise specified, using fluorescein as a reference. 
a
Recorded at 950 nm. 
b
Recorded at 920 nm. 
c
Recorded at 820 nm. 
d
Biphasic assiciation kinetic records were fitted with two 
exponentials. The rate of each phase is given with the relative amplitudes in parentheses. Error represents 
the standard error of the estimate determined from the average of three records. 
e
Ratiometric (F(+Ca2+) 
/F(-Ca2+))exc 492 /(F(+Ca2+) /F(-Ca2+))exc 392.  
f
Recorded at 930 nm. n.d. stands for not determined and n.d.c. for 
no detectable change. 
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k on(lim)
d            k off
d
 - Ca2+  + Ca2+
GCaMP3 6.3 0.33 ± 0.01 3.2 ± 0.1 20 ± 1 1.5 ± 0.1 0.06f 0.76f 5.6
GCaMP3fast 8.8 2.8 ± 0.3 4.3 ± 0.2 145 ± 2 62 ± 2 0.10 0.47 3.4
135 ± 8 (0.5)
19 ± 1 (0.5)
mGCaMP3 EF-1 2.7 ± 0.1 1.1 ± 0.1 4.2 ± 0.2 29 ± 1 14 ± 1 0.30a 1.093a 3.2
mGCaMP3 EF-1:2 1.3 ± 0.1 n.d.c. n.d.c. n.d.c. n.d.c. 1.04 1.05 n.d.
mGCaMP3 EF-1:3 1.5 ± 0.1 4.8 ± 0.3 2.3 ± 0.2 n.d.c. 27 ± 1 0.24 0.36 3.2
mGCaMP3 EF-1:4 3.1 ± 0.2 2.0 ± 0.1 2.9 ± 0.2 21 ± 1 33 ± 1 0.23 0.40 3.7
mGCaMP3 EF-2:3 1.7 ± 0.1 2.0 ± 0.1 3.3 ± 0.2 12 ± 0.3 18 ± 1 0.22 0.47 3.2
mGCaMP3 EF-2:4 3.5 ± 0.1 1.5 ± 0.1 2.9 ± 0.1 9 ± 0.2 31 ± 1 0.27 0.45 3.2
63 ± 6 (0.4)
4.3 ± 0.4 (0.6)
50 ± 4 (0.5)
4.3 ± 0.7 (0.5)
41 ± 4 (0.2)
2.6 ± 0.1 (0.8)
mGCaMP3 RS-1 EF-1:3 1.8 ± 0.1 2.3 ± 0.1 1.6 ± 0.1 n.d.c. 333 ± 83 0.24 0.52 n.d.
mGCaMP3 RS-1 EF-1:4 2.5 ± 0.2 3.4 ± 0.1 2.2 ± 0.1 n.d.c. 414 ± 62 0.13 0.16 3.2
mGCaMP3 RS-1 EF-2:3 1.7 ± 0.1 2.6 ± 0.1 1.7 ± 0.1 n.d.c. 204 ± 26 0.17 0.24 n.d.
mGCaMP3 RS-1 EF-2:4 2.0 ± 0.1 5.3 ± 0.1 1.5 ± 0.1 n.d.c. 208 ± 29 0.17 0.31 n.d.
mGCaMP3 RS-1 EF-3:4 3.1 ± 0.1 3.3 ± 0.1 3.3 ± 0.1 n.d.c. 283 ± 10 0.26 0.42 2.8
2.3 ± 0.1 1.7 ± 0.1 3.0 ± 0.2 18 ± 1 (0.7)
2.7 ± 0.1 294 ± 38 0.8 ± 0.1 2.4 ± 0.1 (0.3)
1.1 ± 0.1 2.3 ± 0.2 3.6 ± 1 12 ± 1 (0.8)
2.1 ± 0.1 534 ± 15 1.1 ± 0.1 1.5 ± 0.1 (0.2)
2.6 ± 0.4 (0.8)
0.9 ± 0.2 (0.2)
1.4 ± 0.1 4.0 ± 0.3 2.5 ± 0.3
2 ± 0.1 873 ± 91 1.0 ± 0.1
1.9 ± 0.1 3.0 ± 0.2 2.6 ± 0.3
3.9 ± 0.1 842 ± 128 1.2 ± 0.1
13 ± 1 (0.7)
1.2 ± 0.1 (0.3)
1.4 ± 0.1 4.1 ± 0.6 1.6 ± 0.3 21 ± 2 (0.8)
3.4 ± 0.2 1084 ± 164 1.0 ± 0.1 3.2 ± 2.5 (0.2)
3.2 ± 0.2 1.1 ± 0.1 4.3 ± 0.2
6.2 ± 0.4 1033 ± 50 1.4 ± 0.1
39 ± 3 (0.5)
1 ± 0.1 (0.5)
15 ± 1 (0.5)
1 ± 0.1 (0.5)
mGEM-GECO EF-1:2 n.d.c. n.d.c. n.d.c. 17 ± 1 2.6 ± 0.1 0.81c 0.73c n.d.
11 ± 1 (0.2)
1 ± 0.1 (0.8)
15 ± 1 (0.5)
1 ± 0.1 (0.5)
11 ± 0.3 (0.4)
2 ± 0.1 (0.6)
mGEM-GECO EF-2:4 31 ± 2e 232 ± 16 1.0 ± 0.1 17 ± 1 8.3 ± 0.2 0.89c 0.68c n.d.
mGEM-GECO EF-3:4 20 ± 3e n.d.c. n.d.c. 4 ± 0.1 2.3 ± 0.1 0.35c 0.30c n.d.
2.00 5.6
1.3 ± 0.1 1.3 ± 0.1 n.d.c. 0.15 0.23 n.d.
3.7
1.9 ± 0.1 1.2 ± 0.1 1.1 ± 0.1 n.d. 0.06
mG-GECO EF-1 18 ± 0.5 0.26 4.8
0.08 n.d.
5.3
mG-GECO EF-1:2 n.d.c.
F /F 0 
(HUVEC) (s-1)
mGCaMP3 RS-1 EF-1:2 2.1 ± 0.1 0.94 ± 0.02 1.7 ± 0.1 n.d.c. 0.30
4.7 ± 0.1 2.8 ± 0.1 0.22
0.09 2.7
mGCaMP3 RS-1 EF-1 2.6 ± 0.1
n.d.
9 ± 0.3 0.21 0.98
 (s-1)
GCaMP3bright 14 0.93 ± 0.01
mG-GECO EF-2 5 ± 0.2 0.23
Protein
F (+Ca
2+
) /     
F (-Ca
2+
)
K d (M) n
2                                           
(10-50 cm4 x s x photon-1)
0.31
15 ± 1
0.64
mGCaMP3 RS-1 EF-2
mGCaMP3 EF-2 2.5 ± 0.1 1.4 ± 0.1 3.6 ± 0.2
0.01
1.29c 1.30c n.d.
mG-GECO EF-1:4 16 ± 1 24 ± 1 0.84 0.84 4.2
mG-GECO EF-1:3 n.d.c. 10 ± 1
n.d.c. n.d.c. n.d.c. 0.08
mG-GECO EF-2:3 2.2 ± 0.1 1770 ± 211 1.0 ± 0.1 5 ± 0.3 0.95 1.00 6.4
mG-GECO EF-2:4 5 ± 0.3 0.91b 0.96b 6.9
n.d.
mGEM-GECO EF-4 92 ± 13e 0.92 ± 0.01 2.7 ± 0.1 1.04 ± 0.01
5.6
0.61b 0.15b n.d.
0.12b
mG-GECO EF-3:4 43 ± 2 74 ± 3 1.58 1.65
mGEM-GECO EF-3 108 ± 8e 1.9 ± 0.1 3.1 ± 0.1 0.08 ± 0.01 0.12b
n.d.
mGEM-GECO EF-1:3 80 ± 2e 0.91 ± 0.01 3.3 ± 0.1 0.30 ± 0.01 0.13c 0.13c n.d.
mGEM-GECO EF-1:4 33 ± 2e 2.7 ± 0.1 2.6 ± 0.1 2.8 ± 0.1 0.37c 0.23c n.d.
mGEM-GECO EF-2:3 42 ± 2e 2.2 ± 0.1 2.4 ± 0.1 4.4 ± 0.1 0.21b 0.13b
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Supplementary Table S3. A set of best-fit parameters for the kinetic model of GCaMP3 and a selection of mGCaMP3. 
a
mGCaMP3 EF-3:4 best fit required that the values for k-1 and k-2 to be orders of magnitude smaller than for GCaMP3 and its EF-hand mutants. Similar 
behaviour characterised the RS-1 peptide mutants for k-1.
b
Irreversible steps are indicated by the small values of rate constants best fit for reversal of peptide 
binding or isomerisation steps. 
 
 
k +1 k -1 k +2 k -2 k +3 k -3 k +4 k -4 k +5 k -5 k +6 k -6 k +7 k -7 k +8 k -8 Kd
(M-1 s-1) (s-1) (M-1 s-1) (s-1) (M-1 s-1) (s-1) (s-1) (s-1) (M-1 s-1) (s-1) (M-1 s-1) (s-1) (M-1 s-1) (s-1) (s-1) (s-1) (M)
GCaMP3 770 1.10E+03 1.50E+04 1.12E+05 1.01E+03 4.90E-05 1.49E+03 168 84 33 25 5.00E-05 1.19E+03 47.5 58 70 21 31 0.351
mGCaMP3 EF-3 770 4.16E+03 1.50E+04 1.82E+03 1.01E+03 2.37E-05 146 199 - - 84 2.00E-04 1.19E+03 2.70E-03 300 10 28 13 0.511
GCaMP3bright 770 4.16E+03 1.50E+04 2.60E+03 1.01E+03 2.37E-05 146 86 84 1.52E-06 - - 1.19E+03 0.05 300 1.27 18 17 0.916
mGCaMP3 EF-3:4 700 0.15 1.21E+03 0.4 268 4.4 378 548 - - - - - - - - 5 - 2.33
mGCaMP3 RS-1 770 13.8a 1.50E+04 1.46E+04 504 38 1.25E+03 21 118 5 25 247 1.86E+03 9.60E-02 1.25E+03 8.0E-03b 5.6 5 0.92
GCaMP3fast 770 2.9 1.50E+04 3.83E+04 786 97 65 176 - - 118 31 960 2.50E-07 368 1.81 27 4.5 3.36
mGCaMP3 RS-1 EF-4 770 2.9 1.50E+04 3.83E+04 786 323 16 74 118 23.6 - - 840 2.90E-08 136 8 53 6.4 5.55
Protein F 1 F 2
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Supplementary Table S4. Absorption properties of mGECI. Extinction coefficients at 280 nm (280) 
were calculated from the amino acid sequence and the extinction coefficient at 400 nm (400) was 
obtained from the A280/A400 ratio. 
 
 
Protein 10-4 x 0 (280 nm) 10-4 x 0 (400 nm)
GCaMP3 2.21
mGCaMP3 EF-1 3.13
mGCaMP3 EF-2 3.41
mGCaMP3 EF-3 3.75
GCaMP3bright 3.00
mGCaMP3 EF-1:2 3.12
mGCaMP3 EF-1:3 3.48
mGCaMP3 EF-1:4 3.75
mGCaMP3 EF-2:3 2.61
mGCaMP3 EF-2:4 3.95
mGCaMP3 EF-3:4 3.00
mGCaMP3 RS-1 2.13
mGCaMP3 RS-1 EF-1 2.62
mGCaMP3 RS-1 EF-2 2.40
GCaMP3fast 2.63
mGCaMP3 RS-1 EF-4 2.67
mGCaMP3 RS-1 EF-1:2 2.67
mGCaMP3 RS-1 EF-1:3 2.65
mGCaMP3 RS-1 EF-1:4 2.45
mGCaMP3 RS-1 EF-2:3 2.92
mGCaMP3 RS-1 EF-2:4 2.85
mGCaMP3 RS-1 EF-3:4 2.97
G-GECO 2.76
mG-GECO EF-1 1.99
mG-GECO EF-2 1.50
mG-GECO EF-3 2.07
mG-GECO EF-4 3.21
mG-GECO EF-1:2 2.09
mG-GECO EF-1:3 1.43
mG-GECO EF-1:4 1.86
mG-GECO EF-2:3 3.57
mG-GECO EF-2:4 2.33
mG-GECO EF-3:4 1.16
GEM-GECO 3.14
mGEM-GECO EF-1 3.22
mGEM-GECO EF-2 3.94
mGEM-GECO EF-3 3.28
mGEM-GECO EF-4 2.50
mGEM-GECO EF-1:2 1.83
mGEM-GECO EF-1:3 1.35
mGEM-GECO EF-1:4 1.83
mGEM-GECO EF-2:3 2.10
mGEM-GECO EF-2:4 2.08
mGEM-GECO EF-3:4 2.90
7.51
7.07
7.66
7.62
